We are a Novanta Company

WHITE PAPER: Machine vision for molecular diagnostics

We are living in the century of biology, and it is affecting our everyday lives.1 Customers,
both physicians and patients, want improved clinical healthcare that is faster, better and
more efficient, and molecular insights may be the ticket that provides it. Therefore, the
demand for differentiated molecular testing solutions is growing. Molecular diagnostics,
including point of care medicine, is the strongest growing market segment in in-vitro
diagnostics. Molecular diagnostic applications include infectious disease, oncology, genetics
and microbiology. Some of the diagnostics are based on DNA characterization
technologies. Fluorescence measurement is the main detection technology used in
molecular diagnostics.